vTv Therapeutics (NASDAQ:VTVT) reported quarterly losses of $(0.06) per share which met the analyst consensus estimate. This is a 45.45 percent increase over losses of $(0.11) per share from the same period last year. The company reported $9.00 thousand in sales this quarter. This is the same as the same period last year.
Adamas One Enters Into A Letter Of Intent With Renowned Digital Agency Neon Flux To Manage Branding And Marketing, E-Commerce, And Fulfillment For Its Luxury Lab-Grown Diamond Jewelry Business
Adamas One Corp. (Nasdaq: JEWL) ("Adamas One," "Adamas" or the "Company"), The Original Lab-Grown Diamond Company™, a high-tech company that leverages proprietary technology to
